Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors

Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors

Background: The majority of patients with epidermal growth factor receptor (EGFR)-mutant advanced non-small cell lung cancer (NSCLC) develop resistance to first- or second-generation EGFR-tyrosine kinase inhibitor (TKI) after a median treatment period of 12 months. This study aimed to determine the...

Full description

Saved in:
Bibliographic Details
Main Authors: Chai, Chee Shee, Liam, Chong Kin, Poh, Mau Ern, Ong, D. B. L., Cheah, P. L., Pang, Yong Kek, Ho, G. F., Alip, A.
Format: Article
Language:en
Published: Elsevier 2019
Subjects:
RC Internal medicine
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Online Access:http://ir.unimas.my/id/eprint/28063/1/WLCC%202019%201.pdf
http://ir.unimas.my/id/eprint/28063/
https://doi.org/10.1016/j.jtho.2019.08.2302
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://ir.unimas.my/id/eprint/28063/1/WLCC%202019%201.pdf
http://ir.unimas.my/id/eprint/28063/
https://doi.org/10.1016/j.jtho.2019.08.2302

Similar Items